EpiCast Report: Postherpetic Neuralgia – Epidemiology Forecast to 2022

Publisher Name :
Date: 22-Oct-2013
No. of pages: 45

Postherpetic Neuralgia (PHN) is one of the most common complications of herpes zoster infection in elderly persons ages 60 years and older, worldwide. The main symptom of PHN is severe pain and allodynia (pain that results from a non-injurious stimulus to the skin). PHN is associated with a significant loss of activity levels and a reduced quality of life, particularly in the elderly. The strongest established risk factor for PHN is advancing age. Other possible risk factors for PHN include severity of acute herpes zoster pain, extent of rash, and duration of prodromal pain.

The number of incident cases of PHN in the 7MM will increase by 20.22% over the next decade, from 241,808 cases in 2012, to 290,694 cases in 2022. Ageand sex-specific incidence data for PHN and herpes zoster, as well as data for the proportion of herpes zoster patients developing PHN in the 7MM, were obtained or calculated from nationally-representative studies in each country to forecast the incident cases of PHN. To maintain a uniform methodology across the markets, GlobalData epidemiologists only used studies that defined PHN as pain persistent for three or more months.

Currently, there is no absolute preventative therapy for PHN. However, a vaccine is available to help prevent a herpes zoster infection; in turn, this vaccine helps reduce the incidence of PHN to an extent because PHN is the sequela of herpes zoster. The considerable increase in the aging population worldwide, coupled with the high risk for developing PHN in elderly herpes zoster patients are expected to impose a considerable burden on healthcare in the 7MM in future years.

Scope

  • The Postherpetic Neuralgia EpiCast Report provides an overview of the risk factors and global trends of postherpetic neuralgia in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast (2012–2022) of the incident cases of postherpetic neuralgia segmented by age (in five-year increments beginning at age 50 and ending at age =85 years) and sex in the 7MM.
  • The postherpetic neuralgia epidemiology report is written and developed by Mastersand PhD-level epidemiologists.
  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 6MM.

Reasons to buy

  • Develop business strategies by understanding the trends shaping and driving the global postherpetic neuralgia market.
  • Quantify patient populations in the global postherpetic neuralgia market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for postherpetic neuralgia therapeutics in each of the markets covered.

EpiCast Report: Postherpetic Neuralgia – Epidemiology Forecast to 2022

Table of Contents

1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6

2 Introduction 7
2.1 Catalyst 7

3 Epidemiology 8
3.1 Disease Overview 8
3.2 Risk Factors and Comorbidities 9
3.2.1 Elderly herpes zoster patients are almost 20 times more likely to develop PHN 9
3.2.2 Herpes zoster vaccine reduces the morbidity of herpes zoster and PHN 11
3.3 Global Trends 11
3.3.1 US 12
3.3.2 France 13
3.3.3 Germany 14
3.3.4 Italy 14
3.3.5 Spain 15
3.3.6 UK 16
3.3.7 Japan 17
3.4 Forecast Metodology 17
3.4.1 Sources Used 19
3.4.2 Forecast Assumptions and Methods 22
3.4.3 Sources Not Used 26
3.5 Epidemiological Forecast of Postherpetic Neuralgia (2012–2022) 27
3.5.1 Incident Cases of PHN 27
3.5.2 Age-Specific Incident Cases of PHN 28
3.5.3 Sex-Specific Incident Cases of PHN 30
3.5.4 Age-Standardized Incidence of PHN 32
3.6 Discussion 33
3.6.1 Epidemiological Forecast Insight 33
3.6.2 Limitations of the Analysis 34
3.6.3 Strengths of the Analysis 35

4 Appendix 37
4.1 Bibliography 37
4.2 About the Authors 40
4.2.1 Epidemiologists 40
4.2.2 Reviewers 40
4.2.3 Franka des Vignes, PhD, Global Director of Epidemiology and Health Policy 42
4.2.4 Bonnie Bain, PhD, Global Head of Healthcare 42
4.3 About GlobalData 43
4.4 About EpiCast 43
4.5 Disclaimer 44

List of Tables

Table 1: 7MM, Sources of PHN Incidence Data 18
Table 2: 7MM, Incident Cases of PHN, Ages ≥50 Years, Men and Women, N, 2012–2022 27
Table 3: 7MM, Incident Cases of PHN, by Age, Men and Women, N (Row %), 2012 29
Table 4: 7MM, Incident Cases of PHN, by Sex, Ages ≥50 Years, N (Row %), 2012 31

List of Figures

Figure 1: 7MM, Incident Cases of PHN, Ages ≥50 Years, Men and Women, N, 2012–2022 28
Figure 2: 7MM, Incident Cases of PHN, by Age, Men and Women, N, 2012 30
Figure 3: 7MM, Incident Cases of PHN, by Sex, Ages ≥50 Years, N, 2012 31
Figure 4: 7MM, Age-Standardized Incidence of PHN (per 1,000 Population), Ages ≥50 Years, Men and Women, 2012 33

  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Growth in the Indian Watch Industry
    Earlier, in India watches were seen as a luxury item. However, watches are now witnessing a fundamental change in perception, and are now gaining respect as an essential utility item. With the liberalization of the Indian market, coupled with the rising purchasing power of the young and consumerist Indians, watch industry in India seems to [...]
  • Global Retail Ready Packaging Market to Witness Steady Growth
    The market for retail ready packaging has witnessed impressive growth in recent years with boom in the retail industry. Retail ready packaging, also known as shelf-ready packaging is designed for the retail outlet, ready to be placed on shelf without any need for unpacking or repacking. In 2011, the global market for retail packaging was [...]
  • 2014 Deep Research Report on Global and China H acid Industry
    Published: 16-Apr-2014        Price: US $2200 Onwards        Pages: 149
    This is a professional and depth research report on Global and China H acid industry. The report firstly introduced H acid basic information included H acid definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, H acid industry policy and plan, H acid product specification, manufacturing process, product cost structure etc. then statis......
  • Fluid Management & Visualization Systems Market by Product (Suction & Irrigation, Dialyzer, Fluid Warming & Waste Management, Endoscopic Camera, Tubing’s, Bloodlines), & Application (GI, Urology, Arthroscopy, Gynecology) – Global Forecasts to 2018
    Published: 16-Apr-2014        Price: US $4650 Onwards        Pages: 360
    The fluid management and visualization systems industry has evolved from traditional standalone systems to modern automated, integrated systems to increase the endosurgical procedure outcomes. Patient safety and security from infections have also gained greater importance in fluid management and visualization systems over the years. Over the past few years, the fluid management and visualization systems market has witnessed a stable growth. The market is expected to grow at a CAGR of 6.1% fro......
  • Iraq Pharmaceuticals and Healthcare Report Q2 2014
    Published: 16-Apr-2014        Price: US $1295 Onwards        Pages: 75
    BMI View: The projected growth of Iraq's pharmaceutical market in 2014 and 2015 is linked to an oildriven economic expansion, which is dependent on the government's ability to represent and appease the country's factions. Given the government's expansionary fiscal policy, spending on education, health and public services will be elevated over the coming quarters. In particular, Baghdad will seek to modernise healthcare provision, in a view to improve support to its rule. Nevertheless, there are ......
  • Lithuania Pharmaceuticals and Healthcare Report Q2 2014
    Published: 16-Apr-2014        Price: US $1295 Onwards        Pages: 98
    BMI View: We expect the Lithuanian pharmaceutical market to post a five-year compound annual growth rate (CAGR) of 4.4%, rising to a value of LTL2.16bn (US$751mn) in 2018. While double-digit annual growth rates are firmly in the past, some opportunities continue to exist in light of epidemiological factors and an ageing population. The upcoming switch to the euro promises to boost purchasing power and stabilise the pharmaceutical market. However, the Lithuanian market will continue to represent ......
  • Sri Lanka Pharmaceuticals and Healthcare Report Q2 2014
    Published: 16-Apr-2014        Price: US $1295 Onwards        Pages: 78
    BMI View: A better-than-expected outlook for Sri Lanka's economy has led us to upwardly revise our pharmaceutical and healthcare forecasts. The government has introduced price controls on wholesale and retail prices of imported drugs, which will limit trade. However, the government's focus on imports of lowcost drugs directly from the governments of Bangladesh and Thailand, using the state pharmaceutical corporation, will limit dependency on Indian exporters. Furthermore, the government's streng......
  • Venezuela Pharmaceuticals and Healthcare Report Q2 2014
    Published: 16-Apr-2014        Price: US $1295 Onwards        Pages: 126
    BMI View: Foreign currency controls and drug price cuts will continue to affect pharmaceutical companies' profitability, with the currency devaluation and high inflation exacerbating the situation. A close relationship and effective communication with the Venezuelan government are vital for the survival of domestic pharmaceutical companies. As the Venezuelan government tries to increase access to medicines, more co-ordination with drug producers to address these issues will become necessary. Hea......
  • Bahrain Pharmaceuticals and Healthcare Report Q2 2014
    Published: 16-Apr-2014        Price: US $1295 Onwards        Pages: 101
    BMI View: This quarter has seen the beginning of a multi-phased plan by the National Health Regulatory Authority to significantly reduce medicine prices in the country, signalling a potential advancement towards the implementation of a unified Gulf Cooperation Council pricing system. Although less optimistic than before, our medium- and long-term outlooks for the Bahrain pharmaceutical market remain bullish. Medicines uptake will be supported by robust economic growth, in addition to the country......
  • Cambodia and Laos Pharmaceuticals and Healthcare Report Q2 2014
    Published: 16-Apr-2014        Price: US $1295 Onwards        Pages: 65
    BMI View: Low health and pharmaceutical expenditures will continue to limit the attractiveness of the pharmaceutical market in Cambodia. Given such a profile, the country will present more commercial benefits to companies dealing with inexpensive generic drugs and over-the-counter products than innovative pharmaceuticals. Headline Expenditure Projections ? Pharmaceuticals: KHR828.7bn (US$210mn) in 2013 to KHR921.9bn (US$230mn) in 2014; +11.2% in local currency terms and +11.8% in US dollar terms......
  • Czech Republic Pharmaceuticals and Healthcare Report Q2 2014
    Published: 16-Apr-2014        Price: US $1295 Onwards        Pages: 104
    BMI View: Overall, the Czech healthcare system is facing severe challenges as it struggles to contain budget deficits. At the same time, demand for the latest pharmaceuticals and access to healthcare services is expected to continue its steady growth trajectory, putting pressure on the state and insurers to raise premiums or redistribute funding. Following the release of pharmaceutical sales data by the SUKL, we have significantly revised down historical values for 2013 and forecasts from 2014 o......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs